UBS Group
MDXG icon

UBS Group’s MiMedx Group MDXG Stock Holding History

UBS Group’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-625,000
Closed -$3.86M – 8192
2018
Q3 		$3.86M Hold
625,000
– – ﹤0.01% 2588
2018
Q2 		$3.99M Buy
+625,000
New +$4.45M ﹤0.01% 2537
2016
Q2 		– Sell
-65,000
Closed -$568K – 7871
2016
Q1 		$568K Buy
+65,000
New +$540K ﹤0.01% 3681

Other funds holding MDXG

Essex Woodlands Management
Essex Woodlands Management The Woodlands, Texas $323M AUM 25.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return
OP Asset Management
OP Asset Management Helsinki $11.8B AUM 34.59% 1-Year Est. Return
Isthmus Partners
Isthmus Partners Madison, Wisconsin $1.04B AUM 19.97% 1-Year Est. Return
Apricus Wealth
Apricus Wealth Beaufort, South Carolina $222M AUM 24.78% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
State of Wyoming
State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return

UBS Group's MDXG Position: Q3 2026 in Review

UBS Group increased its MiMedx Group (MDXG) stake by 236% in Q3 2026, buying an estimated $2.45M and bringing the position to 793,609 shares worth $3.7M. The position accounts for ﹤0.01% of the portfolio, ranked #4402.

UBS Group first reported a position in MDXG in Q4 2014 and has held it in 40 quarters since. The position peaked at $5.29M in Q1 2018. 113 funds tracked by Wall St. Rank hold MDXG as of Q3 2026.

  • UBS Group held 793,609 shares of MiMedx Group worth $3.7M as of Q3 2026.
  • UBS Group bought 557,576 MiMedx Group shares in Q3 2026, an estimated $2.45M.
  • MiMedx Group made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #4402 holding.
  • UBS Group first reported a position in MiMedx Group in Q4 2014 and has held it in 40 quarters since.
  • UBS Group's MiMedx Group position peaked at $5.29M in Q1 2018.
  • 113 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.